H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials
We report on a qualified and adaptable influenza serology method and analysis strategy to measure quantifiable HAI titers to define correlates of vaccine mediated protection in human clinical trials.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Clinical Trials | Guinea Health | H3N2 | Influenza | Influenza Vaccine | National Institutes of Health (NIH) | Oseltamivir | Singapore Health | Statistics | Tamiflu | Vaccines